CME Group (CME) FY2014 results: revenue $3.1 billion, up 6.0% on the year
CME Group Inc. (CME) reported revenue of $3.1 billion for fiscal 2014, the year ended 31 December 2014, up 6.0% on the year before. Net income was $1.1 billion, up 15.4%, and diluted earnings per share $3.35. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2015.
Revenue
$3.1 billion
+6.0% on the year
FY2007FY2014
Operating margin
56.8%
55.8% a year earlier
FY2007FY2014
Net income
$1.1 billion
+15.4% on the year
FY2007FY2014
Diluted EPS
$3.35
+14.7% on the year
FY2007FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
3,112
2,936
2,915
+6.0%
Operating income
1,768
1,637
1,692
+8.0%
Operating margin
56.8%
55.8%
58.1%
Pre-tax income
1,771
1,601
1,693
+10.6%
Income tax
644
623
787
+3.5%
Effective tax rate
36.4%
38.9%
46.5%
Net income
1,127
977
896
+15.4%
Net margin
36.2%
33.3%
30.8%
Diluted EPS
$3.35
$2.92
$2.70
+14.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
1,291
1,280
1,220
+0.9%
Capital expenditure
141
126
142
+12.0%
Free cash flow
1,151
1,155
1,078
-0.4%
Free cash flow margin
37.0%
39.3%
37.0%
Cash from investing
-199
190
-209
Cash from financing
-2,196
-606
-448
Depreciation and amortisation
133
135
137
-1.9%
Share-based compensation
54.8
54.4
61.4
+0.7%
Buybacks
n/a
0.0
0.0
Dividends paid
1,497
599
1,224
+149.8%
Dividend per share
$3.88
$4.40
$3.70
-11.8%
Diluted shares, weighted
336m
334m
332m
+0.5%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
20,924
21,155
21,419
-1.1%
Non-controlling interest
0.0
5.7
5.8
Redeemable equity
n/a
0.0
80.8
Debt
2,108
2,857
2,856
-26.2%
Other liabilities
49,210
30,260
14,501
+62.6%
Total liabilities and equity
72,242
54,278
38,863
+33.1%
Fixed assets
509
513
724
-0.9%
Goodwill
7,569
7,569
7,567
0.0%
Intangible assets
2,637
2,741
2,854
-3.8%
Investments
74.7
68.4
56.6
+9.2%
Trading assets
55.1
49.6
38.7
+11.1%
Cash and equivalents
1,366
2,470
1,605
-44.7%
Receivables
341
303
268
+12.7%
Other assets
59,689
40,564
25,751
+47.1%
Total assets
72,242
54,278
38,863
+33.1%
10-K for the year ended 31 December 2014, filed 26 February 2015: the filing.